Trial Profile
Observation study to assess the effect of Alogliptin on bone metabolism in type 2 diabetic patient
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2013
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 18 Feb 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 19 Aug 2011 New trial record